What is Complete Genomics?
Complete Genomics operates as a research and development center of excellence. Since its inception in June 2005, the company has focused on advancing innovation within its field. The substantial capital injections, totaling $197M, suggest a company with significant operational scope and ambitious development goals. The recent strategic investment of $54M further signals confidence from backers in the company's future prospects and its capacity to execute on its strategic objectives.
How much funding has Complete Genomics raised?
Complete Genomics has raised a total of $197M across 7 funding rounds:
Series A
$6M
Series B
$12M
Series C
$26.5M
Debt
$14.5M
Series D
$45M
Series E
$39M
Stock Offering
$54M
Series A (2006): $6M with participation from Enterprise Partners Venture Capital and OVP Venture Partners
Series B (2007): $12M, investors not publicly disclosed
Series C (2008): $26.5M supported by Prospect Venture Partners III L.P., Highland Crusader Offshore Partners L.P., Enterprise Partners VI L.P., and OVP Venture Partners VI L.P.
Debt (2009): $14.5M, investors not publicly disclosed
Series D (2009): $45M backed by OVP Venture Partners, Essex Woodlands Health Ventures, Highland Capital Partners, Prospect Venture Partners, and OrbiMed
Series E (2010): $39M with participation from OVP Venture Partners, Sands Capital, Essex Woodlands Health Ventures, Highland Capital Partners, Prospect Venture Partners, and OrbiMed
Stock Issuance/Offering (2010): $54M, investors not publicly disclosed
Key Investors in Complete Genomics
OVP Venture Partners
OVP Venture Partners is a venture capital firm with a 26-year history of investing in high-growth technology markets, particularly in cleantech, digital biology, and information technology. They have a strong track record of liquidity events, including IPOs, and manage over $750 million in capital.
Essex Woodlands Health Ventures
EW Healthcare Partners is a healthcare growth equity firm that invests in companies across the US and Europe, focusing on pharmaceuticals, MedTech, and tech-enabled services. They provide capital and strategic guidance to accelerate business growth.
Highland Capital Partners
Highland Capital Partners is a venture capital firm that invests in entrepreneurs and innovative startups, with a significant history of successful exits including IPOs and unicorns. They manage $7 billion in assets and focus on a long-term partnership approach with their portfolio companies.
What's next for Complete Genomics?
The significant enterprise-level funding, culminating in $197M, positions Complete Genomics for substantial expansion and further innovation. The recent strategic investment of $54M is likely to fuel advancements in its core research and development activities, potentially leading to new product launches or market penetration strategies. This capital infusion will enable the company to scale its operations, enhance its technological capabilities, and solidify its competitive standing. The consistent backing from prominent investors highlights a strong belief in the company's long-term vision and its potential for significant returns.
See full Complete Genomics company page
